Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach

Publisher： John Wiley & Sons Inc

E-ISSN： 1549-490x|23|2|171-178

ISSN： 1083-7159

Source： The Oncologist, Vol.23, Iss.2, 2018-02, pp. : 171-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy of Cancer. Edited by Edmund C. Lattime, Stanton L. Gerson, Academic Press, San Diego, California, 1999

By Alvarez R.D.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 341-341

Elsevier

Access to resources Recommend Favorite

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results. Rini BI, Zimmerman T, Stadler WM, Gajewski TF, Vogelzang NJ, University of California San Francisco, Comprehensive Cancer Center, San Francisco, CA - J Clin Oncol 2002;20:2017-2024

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 412-413

Elsevier

Access to resources Recommend Favorite

Trailblazing Precision Oncology for Rare Tumor Subtypes

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 143-144

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience

By  

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 128-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypoxia-activated prodrugs in cancer therapy: progress to the clinic

By Denny William A  

Future Oncology, Vol. 6, Iss. 3, 2010-03 ,pp. : 419-428

Future Medicine

Access to resources Recommend Favorite